← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2010Last known activity
Sep 21, 2022
Timeline
2010s
- Jan 1, 2010
University of Eastern Finland— Founded
Drugs by trial phase (25 distinct, 22 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Abortion, Spontaneous
- Angina Pectoris
- Coronary Artery Disease
- Coronary Disease
- Diabetes, Gestational
- Fractures, Bone
- Glioblastoma
- Heart Diseases
- Infarction
- Infertility
- Menorrhagia
- Myocardial Infarction
- Myocardial Ischemia
- Neurobehavioral Manifestations
- Osteoarthritis
- Osteoporosis
- Polycystic Ovary Syndrome
- Prostatic Neoplasms
- Schizophrenia
- Stroke
- Syndrome
- Toxemia
Recent trials (35)
- NCT05328180CollaboratorN/ASep 21, 2022
- NCT05182658CollaboratorPhase 3Jun 1, 2022
- NCT04150926Lead sponsorN/AAug 15, 2019
- NCT03572205Lead sponsorN/AAug 31, 2018
- NCT03572205Overall official - principal investigatorN/AAug 31, 2018
- NCT03570450CollaboratorPhase 1Jun 2, 2018
- NCT03537027Reponsible party - principal investigatorPhase 1May 3, 2018
- NCT03537027Overall official - principal investigatorPhase 1May 3, 2018
- NCT03537027Lead sponsorPhase 1May 3, 2018
- NCT03469089Study directorPhase 1Mar 12, 2018
- NCT03469089Lead sponsorPhase 1Mar 12, 2018
- NCT01777919CollaboratorPhase 2Jan 1, 2017
- NCT02849613CollaboratorPhase 2/Phase 3Mar 31, 2016
- NCT02543216Reponsible party - principal investigatorN/AJan 1, 2015
- NCT02543216Lead sponsorN/AJan 1, 2015
Details
- Founded
- Joensuu, FI Jan 1, 2010
- Last known activity
- Sep 21, 2022